Literature DB >> 15703197

Distribution and kinetics of SR-PSOX/CXCL16 and CXCR6 expression on human dendritic cell subsets and CD4+ T cells.

Sumie Tabata1, Norimitsu Kadowaki, Toshio Kitawaki, Takeshi Shimaoka, Shin Yonehara, Osamu Yoshie, Takashi Uchiyama.   

Abstract

Dendritic cells (DCs) coordinate T cell responses by producing T cell-attracting chemokines and by inducing the expression of chemokine receptors on T cells. Scavenger receptor for phosphatidylserine and oxidized lipoprotein (SR-PSOX)/CXC chemokine ligand 16 (CXCL16) is a unique chemokine that also functions as an endocytic receptor and an adhesion molecule in its membrane-bound form. SR-PSOX/CXCL16 is the only known ligand of CXC chemokine receptor 6 (CXCR6) that is expressed on activated T cells and thus, may play an important role in enhancing effector functions of T cells. Here, we investigated the expression of SR-PSOX/CXCL16 on human DC subsets and that of CXCR6 on T cell subpopulations to elucidate the dynamics of CXCL16/CXCR6 interaction in DC/T cell responses. Membrane-bound SR-PSOX/CXCL16 was expressed on macrophages, monocyte-derived DCs, and blood myeloid DCs, and the expression increased after DC maturation. Myeloid antigen-presenting cells constitutively secreted SR-PSOX/CXCL16 for an extended period, suggesting the involvement of CXCL16 in peripheral and lymphoid tissues. Plasmacytoid DCs hardly expressed SR-PSOX/CXCL16 on their surfaces but secreted significant amounts of SR-PSOX/CXCL16. A subset of CD4+ effector memory T (T(EM)) cells constitutively expressed CXCR6, whereas central memory T cells (T(CM)) and naive T cells did not. Upon stimulation with mature DCs, however, the expression of CXCR6 on T(CM) cells was markedly up-regulated, whereas the expression on naive T cells was induced only weakly. These results suggest that the interaction between SR-PSOX/CXCL16 and CXCR6 plays an important role in enhancing T(CM) cell responses by mature DCs in lymphoid tissues and in augmenting T(EM) cell responses by macrophages in peripheral inflamed tissues.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15703197     DOI: 10.1189/jlb.1204733

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  29 in total

1.  Atherogenic lipids induce high-density lipoprotein uptake and cholesterol efflux in human macrophages by up-regulating transmembrane chemokine CXCL16 without engaging CXCL16-dependent cell adhesion.

Authors:  Jana Barlic; Wenjia Zhu; Philip M Murphy
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

2.  CXCR6 identifies a putative population of retained human lung T cells characterised by co-expression of activation markers.

Authors:  Angela J Morgan; Cristina Guillen; Fiona A Symon; Surinder S Birring; James J Campbell; Andrew J Wardlaw
Journal:  Immunobiology       Date:  2008-03-07       Impact factor: 3.144

3.  An alternatively spliced CXCL16 isoform expressed by dendritic cells is a secreted chemoattractant for CXCR6+ cells.

Authors:  Robbert van der Voort; Viviènne Verweij; Theo M de Witte; Edwin Lasonder; Gosse J Adema; Harry Dolstra
Journal:  J Leukoc Biol       Date:  2010-02-24       Impact factor: 4.962

4.  Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid.

Authors:  Tatjana Marinkovic; Alexandre Garin; Yoshifumi Yokota; Yang-Xin Fu; Nancy H Ruddle; Glaucia C Furtado; Sergio A Lira
Journal:  J Clin Invest       Date:  2006-09-21       Impact factor: 14.808

5.  CXCR6 is expressed on T cells in both T helper type 1 (Th1) inflammation and allergen-induced Th2 lung inflammation but is only a weak mediator of chemotaxis.

Authors:  Markus Latta; Karkada Mohan; Thomas B Issekutz
Journal:  Immunology       Date:  2007-04-16       Impact factor: 7.397

6.  Circulating levels of the chemokine CCL18 but not CXCL16 are elevated and correlate with disease activity in rheumatoid arthritis.

Authors:  Antoine W T van Lieshout; Jaap Fransen; Marcel Flendrie; Agnes M M Eijsbouts; Frank H J van den Hoogen; Piet L C M van Riel; Timothy R D J Radstake
Journal:  Ann Rheum Dis       Date:  2007-03-09       Impact factor: 19.103

7.  Expression analysis and clinical significance of CXCL16/CXCR6 in patients with bladder cancer.

Authors:  Jun Taik Lee; Sang Don Lee; Jeong Zoo Lee; Moon Kee Chung; Hong Koo Ha
Journal:  Oncol Lett       Date:  2012-10-17       Impact factor: 2.967

8.  CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein.

Authors:  Paul Gutwein; Mohamed Sadek Abdel-Bakky; Anja Schramme; Kai Doberstein; Nicole Kämpfer-Kolb; Kerstin Amann; Ingeborg A Hauser; Nicholas Obermüller; Christine Bartel; Abdel-Aziz H Abdel-Aziz; El Sayed M El Sayed; Josef Pfeilschifter
Journal:  Am J Pathol       Date:  2009-05-12       Impact factor: 4.307

9.  SIV-induced Translocation of Bacterial Products in the Liver Mobilizes Myeloid Dendritic and Natural Killer Cells Associated With Liver Damage.

Authors:  Tristan I Evans; Haiying Li; Jamie L Schafer; Nichole R Klatt; Xing-Pei Hao; Ryan P Traslavina; Jacob D Estes; Jason M Brenchley; R Keith Reeves
Journal:  J Infect Dis       Date:  2015-08-03       Impact factor: 5.226

10.  LysoPtdOH enhances CXCL16 production stimulated by LPS from macrophages and regulates T cell migration.

Authors:  Shijun Kang; Chunlan Yang; Rongcheng Luo
Journal:  Lipids       Date:  2008-10-02       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.